| Literature DB >> 27626111 |
Xinzhou Yang1, Mi Huang1, Jinyan Cai2, Dan Lv3, Jingnan Lv1, Sijian Zheng1, Xinhua Ma1, Ping Zhao1, Qiang Wang3.
Abstract
An EtOAc fraction from the roots of Caragana tangutica Maxim. (CTEA) displayed promising anti-hepatocellular carcinoma (HCC) activity during screening of a traditional Chinese ethnic herb library against HepG2 and Hep3B cell lines. HPLC-based activity profiling of CTEA by combination of MS-guided large-scale semi-preparative HPLC and NMR methods led to the identification of a new pterocarpan glycoside, (-)-maackiain 3-O-6'-O-methyl malonyl-β-d-glucopyranoside (1), together with three known pterocarpan glycosides, (-)-maackiain 3-O-β-d-glucopyranoside (2), 3-O-6'-O-acrylyl-β-d-galactopyranoside (3), and (-)-maackiain 3-O-6'-O-acetyl-β-d-glucopyranoside (4). Compound 1 was isolated during a drug discovery programme aimed at identifying new anti-HCC leads from a natural product library. Anti-HCC study showed that all four compounds exhibited cytotoxic activity with IC50 values range of 29.1-53.5 μg/mL against HepG2 and Hep3B cell lines.Entities:
Keywords: Anti-hepatocellular carcinoma; Caragana tangutica; Tibetan medicines; pterocarpan glycosides
Mesh:
Substances:
Year: 2016 PMID: 27626111 DOI: 10.1080/14786419.2016.1230118
Source DB: PubMed Journal: Nat Prod Res ISSN: 1478-6419 Impact factor: 2.861